CIPLA Share Price Performance
₹1,401.30
-102.90 (-6.84%)
4.0% undervalued intrinsic discount
₹1,459.57
Fair Value
Price ₹1,401.30
AnalystConsensusTarget ₹1,459.57
Fair Value₹1,459.57
Share Pricen/a
Narrative Update • Jun 05
Cipla Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 46 Fair Values set on narratives written by author
CIPLA Community Narratives
AN
Fair Value
·Fair Value ₹1.46k 4.0% undervalued intrinsic discount
Emerging Markets And Chronic Therapies Will Open New Horizons
0users have liked this narrative
0users have commented on this narrative
26users have followed this narrative
Emerging Markets And Chronic Therapies Will Open New Horizons
Cipla looks set to ride rising healthcare demand in places like India and Africa, helped by a bigger push into long-term treatments and newer, harder-to-make medicines in the U.S. But the upside depends on avoiding U.S. drug price pressure and keeping product launches and regulators onside.Read more
AN
₹1.46k
4.0% undervalued intrinsic discount
Fair Value
Revenue
10.84% p.a.
Profit Margin
15.24%
Future PE
29.05x
Price in 2029
₹2.08k
Trending Discussion
Recently Updated Narratives
AN
CIPLA: Fair Outlook As New CEO And Respiratory Portfolio Changes Take Shape
Fair Value: ₹1.46k 4.0% undervalued intrinsic discount
26 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Cipla Limited Key Details
About CIPLA
- Founded
- 1935
- Employees
- 31369
- CEO
- WebsiteView website
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
